|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6 Suppl
|
|
pubmed:dateCreated |
2006-12-22
|
|
pubmed:abstractText |
Cerebellar mutism syndrome (CMS) is a unique postoperative syndrome typically arising 1 to 2 days after resection of a midline posterior fossa tumor; it consists of diminished speech progressing to mutism, emotional lability, hypotonia, and ataxia. Most descriptions have been limited to small institutional series using a retrospective chart review methodology.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0022-3085
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
105
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
444-51
|
|
pubmed:dateRevised |
2009-6-26
|
|
pubmed:meshHeading |
pubmed-meshheading:17184075-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:17184075-Cerebellar Neoplasms,
pubmed-meshheading:17184075-Child,
pubmed-meshheading:17184075-Child, Preschool,
pubmed-meshheading:17184075-Combined Modality Therapy,
pubmed-meshheading:17184075-Female,
pubmed-meshheading:17184075-Humans,
pubmed-meshheading:17184075-Incidence,
pubmed-meshheading:17184075-Infant,
pubmed-meshheading:17184075-Male,
pubmed-meshheading:17184075-Medulloblastoma,
pubmed-meshheading:17184075-Mutism,
pubmed-meshheading:17184075-Neuroectodermal Tumors, Primitive,
pubmed-meshheading:17184075-Postoperative Complications,
pubmed-meshheading:17184075-Prognosis,
pubmed-meshheading:17184075-Prospective Studies,
pubmed-meshheading:17184075-Risk Factors,
pubmed-meshheading:17184075-Severity of Illness Index
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Incidence and severity of postoperative cerebellar mutism syndrome in children with medulloblastoma: a prospective study by the Children's Oncology Group.
|
|
pubmed:affiliation |
Department of Pediatrics, University of Michigan Health System, Ann Arbor, Michigan 48109-0203, USA. prob@umich.edu
|
|
pubmed:publicationType |
Journal Article,
Multicenter Study,
Clinical Trial, Phase II,
Clinical Trial, Phase III,
Research Support, N.I.H., Extramural
|
